Mesotherapy-associated Outbreak Caused by Mycobacterium immunogenum
Marcelo del Castillo, Domingo Palmero , Beatriz Lopez, Roxana Paul, Viviana Ritacco, Pablo Bonvehi, Liliana Clara, Marta Ambroggi, Lucía Barrera, and Carlos Vay
Author affiliations: Sanatorio Mater Dei, Buenos Aires, Argentina (M. del Castillo, C. Vay); Hospital F.J. Muñiz, Buenos Aires (D. Palmero, M. Ambroggi); Instituto Nacional de Enfermedades Infecciosas ANLIS C. G. Malbrán, Buenos Aires (B. Lopez, R. Paul, V. Ritacco, L. Barrera); Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires (V. Ritacco); Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires (P. Bonvehi); Hospital Italiano, Buenos Aires (L. Clara); Universidad de Buenos Aires, Buenos Aires (C. Vay)
Figure. DNA enterobacterial repetitive intergenic consensus PCR (eric) analysis of rapidly growing mycobacteria isolated from 3 patients in a mesotherapy-associated outbreak, January–February, 2007, Buenos Aires city, Argentina, compared with profiles of epidemiologically unrelated clinical isolates of the Mycobacterium abscessus–M. chelonae group. The dendrogram was constructed with the aid of BioNumerics software v 4.6 (Applied Maths, Sint-Martens-Latem, Belgium), using Dice unweighted pair group method coefficients with 1% tolerance. PRA, PCR-restriction analysis of the hsp65 gene.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.